📣 Help Shape the Future of UKRI's Gateway to Research (GtR)

We're improving UKRI's Gateway to Research and are seeking your input! If you would be interested in being interviewed about the improvements we're making and to have your say about how we can make GtR more user-friendly, impactful, and effective for the Research and Innovation community, please email gateway@ukri.org.

A seven-Gene Signature assay improves prognostic risk stratification of perioperative chemotherapy treated gastroesophageal cancer patients from the MAGIC trial. (2018)

First Author: Smyth EC

Attributed to: CANCER: Trials with potential global reach and other challenging trials funded by MRC

Abstract

No abstract provided

Bibliographic Information

Digital Object Identifier: http://dx.doi.org/10.1093/annonc/mdy407

PubMed Identifier: 30481267

Publication URI: http://europepmc.org/abstract/MED/30481267

Type: Journal Article/Review

Volume: 29

Parent Publication: Annals of oncology : official journal of the European Society for Medical Oncology

Issue: 12

ISSN: 0923-7534